Skip to main content

Closed

CGEN: Compugen Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Operating margin42.3%

ROIC24.7%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage0.0×

Current ratio6.23×

Valuation

Unrated

P/E ratio6.4×

Compugen Ltd.

CGENNASDAQ Global Market·USD·Closed

Compugen Ltd.

CGENNASDAQ·USD·Closed

$2.35

+0.64%

$2.35

+$0.02 (0.64%)

52W Range

54thpctl

Volume

0.87×avg

Mkt Cap

222.20MUSD

P/E

6.4TTM

Div Yield

–ann

52W Range

54thpctl

Volume

0.87×avg

Market Cap

222.20MUSD

P/E Ratio

6.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings